Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free KTTA Stock Alerts

Pasithea Therapeutics (KTTA) Earnings Date, Estimates & Call Transcripts

Pasithea Therapeutics logo
$0.58 +0.00 (+0.02%)
As of 09/3/2026 04:00 PM Eastern
Compare

Pasithea Therapeutics Earnings Summary

Pasithea Therapeutics announced Q2 2026 earnings on August 14, 2026, reporting an EPS of -$0.16, which hit analysts' consensus estimates of -$0.16. With a trailing EPS of -$1.58, Pasithea Therapeutics' earnings are expected to grow next year, from ($0.76) to ($0.46) per share.

Upcoming Q3
Earnings Date
Nov. 12After Market ClosesEstimated
Consensus EPS
(Aug. 14)
-$0.16
Actual EPS
(Aug. 14)
-$0.16

Q2 2026 Earnings Resources

KTTA Upcoming Earnings

Pasithea Therapeutics' next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Powered by Quartr
Get Pasithea Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pasithea Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

KTTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Pasithea Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.45-$0.45-$0.45
Q2 20261-$0.16-$0.16-$0.16
Q3 20261-$0.21-$0.21-$0.21
Q4 20261-$0.25-$0.25-$0.25

Pasithea Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2026
(Estimated)		--------
8/14/2026Q2 2026-$0.16-$0.16--$0.16$0.30M-
5/15/2026Q1 2026-$0.45-$0.12+$0.33-$0.12$0.10M-
3/30/2026Q4 2025-$0.18-$0.89 -$0.71-$0.89$0.10M-
11/13/2025Q3 2025--$0.41--$0.41--
8/14/2025Q2 2025--$0.66--$0.66--
5/15/2025Q1 2025--$1.61--$1.61--
3/24/2025Q4 2024--$2.41--$2.41--

Pasithea Therapeutics Earnings - Frequently Asked Questions

Pasithea Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 12th, 2026 based off last year's report dates. Learn more on KTTA's earnings history.

In the previous quarter, Pasithea Therapeutics (NASDAQ:KTTA) reported ($0.16) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.16). Learn more on analysts' earnings estimate vs. KTTA's actual earnings.

Pasithea Therapeutics (NASDAQ:KTTA) has a recorded net income of -$20.43 million. KTTA has generated -$1.58 earnings per share over the last four quarters.

Pasithea Therapeutics' earnings are expected to grow from ($0.76) per share to ($0.46) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:KTTA is sourced from Fiscal.ai, with the most recent quarter reported on 8/14/2026. New results are added as companies report their earnings.
From Our Partners
The 2026 beginners Guide to Gold IRAs
Gold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...
Goldco Direct, LLC | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
Are you leaving Social Security money on the table?
Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....
Money Pickle | Sponsoredtc pixel
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel